Sterility vs. Purity: Two Different COA Questions Most Buyers Confuse
The Single Number That Misleads Most Buyers
When a research-peptide vendor advertises “99% purity,” many buyers treat that figure as a comprehensive quality stamp — a single number that answers every relevant question about the product. It does not. That number answers exactly one question: what fraction of the detectable material in the sample is the intended peptide by HPLC chromatography.
Purity and sterility are separate analytical dimensions. Confusing them is one of the most common and consequential mistakes a peptide buyer can make. This article unpacks what each measurement actually captures, why both matter for rigorous research, and what a complete Certificate of Analysis (COA) looks like when a vendor takes quality documentation seriously.
What Purity Testing Actually Measures
HPLC: A Chromatographic Snapshot
High-performance liquid chromatography (HPLC) separates a sample’s components based on their interaction with a stationary phase and a mobile phase. The detector — most commonly a UV absorbance detector — measures how much material passes through at each moment. The resulting chromatogram shows peaks, and the area under the target peak divided by the total peak area gives the purity percentage.
What this captures well:
- Truncated sequences — incomplete peptide chains produced during synthesis
- Deletion sequences — variants missing one or more amino acids
- Oxidation or deamidation products — common chemical degradation artifacts
- Residual protecting groups left over from solid-phase synthesis
What HPLC does not capture:
- Bacteria, fungi, or their spores
- Endotoxins (lipopolysaccharides from gram-negative bacterial cell walls)
- Particulate contamination
- Residual solvents below UV-detectable thresholds
A peptide can produce a clean, single-peak chromatogram and still harbor meaningful microbial or endotoxin contamination. The chemistry looks fine; the biology is a different story.
Mass Spectrometry: Confirming Identity
Mass spectrometry (MS) complements HPLC by confirming the molecular weight of the detected compound. If the observed m/z value matches the theoretical molecular weight of the target peptide, that is strong evidence the correct compound was synthesized. MS does not quantify purity on its own, but together with HPLC it provides the foundation of chemical identity verification.
What Sterility Testing Actually Measures
Bioburden and Sterility Assays
Sterility testing asks a fundamentally different question: is there living microbial contamination in this product? Standard methods involve culturing the sample (or a filtered portion of it) in nutrient media under conditions favorable to bacterial and fungal growth, then observing whether growth occurs over an incubation period. A passing result means no detectable viable organisms were recovered under the test conditions.
This test is entirely invisible to HPLC. A chromatogram has no mechanism to detect a bacterium.
Endotoxin Testing: The Invisible Contaminant
Even if all viable bacteria are eliminated — say, through sterile filtration — their cellular debris can remain. Gram-negative bacteria release lipopolysaccharide (LPS) fragments called endotoxins when their cell walls break down. Endotoxins are heat-stable, sub-microscopic, and pass through standard 0.22 µm filters under some conditions.
The standard detection method is the Limulus Amebocyte Lysate (LAL) assay, which uses a clotting cascade derived from horseshoe crab blood to detect endotoxin at very low concentrations, typically expressed in Endotoxin Units per milliliter (EU/mL). Recombinant Factor C (rFC) assays serve as a modern, animal-free alternative.
Endotoxin results are reported as a concentration figure against an acceptance criterion — not simply “pass/fail” without a stated limit. A COA that says only “endotoxin: negative” without a stated detection threshold is providing incomplete information.
Why Both Documents Need to Appear on the Same COA
A COA that reports only HPLC purity is answering half the question. For in vitro cell-based assays, endotoxin contamination can confound results by triggering non-specific immune-pathway activation in cultured cells — making data interpretation unreliable. For in vivo research models, the stakes of uncharacterized bioburden are even more significant.
The practical standard a buyer should demand from any vendor:
| Test | What It Confirms |
|---|---|
| HPLC (≥98% typical) | Chemical purity, absence of major synthesis impurities |
| Mass Spectrometry | Correct molecular identity |
| Endotoxin (LAL/rFC) | Absence of lipopolysaccharide contamination |
| Sterility / Bioburden | Absence of viable microbial organisms |
| Batch Number | Traceability — results tied to a specific production lot |
No batch number means the COA is not traceable. An untraceable COA is effectively decorative.
The Verification Standard Worth Holding Vendors To
Most buyers don’t know to ask for all five of the above — and many vendors count on that. A vendor publishing only a purity percentage without batch-linked endotoxin and identity confirmation is not meeting a reasonable analytical standard for research-grade materials.
The benchmark is straightforward: every lot should ship with a COA containing a unique batch number, an HPLC chromatogram, mass spec confirmation, and an endotoxin result with a stated limit. If those documents are not publicly available or not provided on request, the quality claim is unverifiable.
Peptides Optimized publishes third-party COAs meeting this standard — batch-numbered, with HPLC, mass spec, and endotoxin data — so researchers can verify quality before ordering rather than taking a vendor’s word for it. That is the level of documentation the rest of the industry should be measured against.
All content on PeptideReceipts.com is for educational purposes only. Research peptides are sold for laboratory and research use only — not for human consumption, therapeutic use, or clinical application.
Frequently Asked Questions
What does HPLC purity actually measure in a peptide COA?
HPLC purity measures the percentage of the target peptide relative to all UV-absorbing species detected in the sample. A result of ≥98% means roughly 98% of the detectable material elutes at the expected retention time. It tells you nothing about microbial contamination, endotoxin load, or particulate matter.
Can a peptide be 99% pure and still be unsafe for research use?
Yes. High chromatographic purity confirms chemical identity and relative composition, but it does not confirm the absence of bacteria, fungi, or endotoxins. A product synthesized in a non-sterile environment can carry significant bioburden even while reporting near-perfect HPLC purity.
What is an endotoxin test and why does it appear on some COAs?
Endotoxin testing — typically performed via Limulus Amebocyte Lysate (LAL) assay or recombinant Factor C assay — detects lipopolysaccharide fragments shed by gram-negative bacteria. Even trace endotoxin levels can trigger strong inflammatory responses in biological systems, making this test critical for any in vitro or in vivo research application.
What should a complete research-peptide COA include beyond HPLC purity?
A thorough COA should include HPLC chromatogram with retention time, mass spectrometry (MS) confirmation of molecular weight, endotoxin test result with a stated limit, moisture or water content (often by Karl Fischer titration), and ideally a sterility or bioburden test. Each document should carry a unique batch number so results are traceable to a specific production lot.